[HTML][HTML] Drug-eluting stents
HM García-García, S Vaina, K Tsuchida… - Archivos de cardiologia …, 2006 - scielo.org.mx
Stent implantation was developed to overcome the acute recoil and high restenosis rate of
balloon angioplasty, but resulted in the development of chronic in–stent restenosis related to …
balloon angioplasty, but resulted in the development of chronic in–stent restenosis related to …
Transcriptional regulation of MYC through G-quadruplex structures
S Balaratnam, JS Schneekloth Jr - Annual Reports in Medicinal Chemistry, 2020 - Elsevier
The MYC gene codes for the expression of MYC (also known as c-Myc), a transcription
factor that regulates the expression of diverse genes and is important for global …
factor that regulates the expression of diverse genes and is important for global …
Nanotechnology-based gene-eluting stents
Cardiovascular disease is one of the major causes of death in the world. Coronary stenting
in percutaneous coronary intervention (PCI) has revolutionized the field of cardiology …
in percutaneous coronary intervention (PCI) has revolutionized the field of cardiology …
First human experience with local delivery of novel antisense AVI-4126 with Infiltrator catheter in de novo native and restenotic coronary arteries: 6-month clinical and …
N Kipshidze, P Iversen, P Overlie, T Dunlap… - Cardiovascular …, 2007 - Elsevier
BACKGROUND: A novel antisense phosphorodiamidate morpholino oligomer, AVI-4126,
was shown to be effective in reducing neointimal formation in different animal models …
was shown to be effective in reducing neointimal formation in different animal models …
Modulating the functional contributions of c-Myc to the human endothelial cell cyclic strain response
NE Hurley, LA Schildmeyer, KA Bosworth… - Journal of vascular …, 2009 - karger.com
This study addresses whether pathological levels of cyclic strain activate the c-Myc
promoter, leading to c-Myc transcription and downstream gene induction in human umbilical …
promoter, leading to c-Myc transcription and downstream gene induction in human umbilical …
Efficacy of a phosphorodiamidate morpholino oligomer antisense compound in the inhibition of corneal transplant rejection in a rat cornea transplant model
A Hosseini, FA Lattanzio Jr, SS Samudre… - Journal of ocular …, 2012 - liebertpub.com
Purpose: The cornea is one of the most commonly transplanted tissues. The morpholino-
oligomer antisense compound AVI-5126 suppresses expression of proto-oncogene c-myc, a …
oligomer antisense compound AVI-5126 suppresses expression of proto-oncogene c-myc, a …
c-Myc antisense oligonucleotides preserve smooth muscle differentiation and reduce negative remodelling following rat carotid arteriotomy
A Forte, U Galderisi, M De Feo, MF Gomez… - Journal of vascular …, 2005 - karger.com
Objectives: The vascular biology of restenosis is complex and not fully understood, thus
explaining the lack of effective therapy for its prevention in clinical settings. The role of c-Myc …
explaining the lack of effective therapy for its prevention in clinical settings. The role of c-Myc …
Study on ultrasonic spray technology for the coating of vascular stent
H Yi, J Huang, XZ Gu, ZH Ni - Science China Technological Sciences, 2011 - Springer
The ultrasonic spray technology is studied by the method of theoretical derivation, CFD
simulation, spray particle diameter detection and analysis, and experimental analysis. And …
simulation, spray particle diameter detection and analysis, and experimental analysis. And …
Controlled delivery of antisense oligodeoxynucleotide from cationically modified phosphorylcholine polymer films
ZQ Zhang, XC Cao, XB Zhao, SB Withers… - …, 2006 - ACS Publications
Antisense strategy is a promising approach for the prevention of in-stent restenosis if
therapeutic agents such as antisense oligodeoxynucleotides (AS-ODNs) can be …
therapeutic agents such as antisense oligodeoxynucleotides (AS-ODNs) can be …